Moreover, activation of KRAS was also reported to be associated with increased numbers of γδTCR+ inflammatory cells, which are a non-MHC-restricted lymphocyte subset closely associated with innate immunity and implicated in accelerated tumor formation (174). This evidence concerns the gene KRAS and neoplasm.